Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: AVIR) Delayed: 5.27 -0.41 (7.22%)
Previous Close $5.68    52 Week High $2.00 
Open $5.64    52 Week Low $1.15 
Day High $5.66    P/E N/A 
Day Low $5.24    EPS $0.00 
Volume 430,820